Documents
Application Sponsors
NDA 021963 | SANOFI AVENTIS US | |
Marketing Status
Application Products
001 | SUSPENSION;ORAL | 30MG/5ML | 1 | ALLEGRA | FEXOFENADINE HYDROCHLORIDE |
FDA Submissions
TYPE 3; Type 3 - New Dosage Form | ORIG | 1 | AP | 2006-10-16 | STANDARD |
LABELING; Labeling | SUPPL | 2 | AP | 2008-06-25 | STANDARD |
LABELING; Labeling | SUPPL | 7 | AP | 2019-05-30 | STANDARD |
Submissions Property Types
CDER Filings
SANOFI AVENTIS US
cder:Array
(
[0] => Array
(
[ApplNo] => 21963
[companyName] => SANOFI AVENTIS US
[docInserts] => ["",""]
[products] => [{"drugName":"ALLEGRA","activeIngredients":"FEXOFENADINE HYDROCHLORIDE","strength":"30MG\/5ML","dosageForm":"SUSPENSION;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
[labels] => [{"actionDate":"05\/30\/2019","submission":"SUPPL-7","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/021963s007lbl.pdf\"}]","notes":""},{"actionDate":"06\/25\/2008","submission":"SUPPL-2","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2008\\\/020872s018,021963s002lbl.pdf\"}]","notes":""},{"actionDate":"10\/16\/2006","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/021963lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"ALLEGRA","submission":"FEXOFENADINE HYDROCHLORIDE","actionType":"30MG\/5ML","submissionClassification":"SUSPENSION;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
[supplements] =>
[actionDate] => 2019-05-30
)
)